DNLI
Denali Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$20.57
-0.13 ▼ -0.63%
🌙 3월 13일 6:49 PM ET (한국 3/14 07:49)
$20.50
-0.07 ▼ -0.34%
| Index | RUT | P/E | - | EPS (ttm) | -2.97 | Insider Own | 10.76% | Shs Outstand | 0.16B | Perf Week | 4.47% |
| Market Cap | 3.26B | Forward P/E | - | EPS next Y | 6.82% | Insider Trans | -0.31% | Shs Float | 0.14B | Perf Month | 4.47% |
| Enterprise Value | 2.44B | PEG | - | EPS next Q | -0.66 | Inst Own | 95.14% | Short Float | 10.12% | Perf Quarter | 17.07% |
| Income | -0.51B | P/S | - | EPS this Y | 10.53% | Inst Trans | 8.35% | Short Ratio | 9.01 | Perf Half Y | 38.8% |
| Sales | 0.00B | P/B | 3.17 | EPS next 5Y | 34.36% | ROA | -40.69% | Short Interest | 14.32M | Perf YTD | 24.59% |
| Book/sh | 6.49 | P/C | 3.76 | EPS past 3/5Y | -4.56% - | ROE | -45.69% | 52W High | -13.46% ($23.77) | Perf Year | 38.15% |
| Cash/sh | 5.47 | P/FCF | - | Sales past 3/5Y | - | ROIC | -48.98% | 52W Low | 94.61% ($10.57) | Perf 3Y | -12.32% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -15.3% | Gross Margin | - | Volatility(W/M) | 5.99% 5.74% | Perf 5Y | -68.2% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 1.21 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.16 | EPS Q/Q | -8.58% | Profit Margin | - | RSI (14) | 50.68 | Recom | 1.17 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.16 | Sales Q/Q | - | SMA20 | 0.03% ($20.56) | Beta | 1.08 | Target Price | $32.93 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2000000 | SMA50 | 3.97% ($19.78) | Rel Volume | 0.81 | Prev Close | $20.7 |
| Employees | 503 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 0.94% -100% | SMA200 | 24.67% ($16.5) | Avg Volume(3M) | 1.59M | Price | $20.57 |
| IPO | 2017/12/8 | Option/Short | Yes/Yes | Trades | 12273 | Volume | 1,290,238 | Change | -0.63% |
뉴스 로딩 중...